Related Experiment Videos
Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation
F M Santorelli1, S C Mak, M E Vazquez-Memije
1H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Columbia University, New York, New York 10032, USA.
Pediatric Research
|May 1, 1996
Summary
The T8993C mitochondrial DNA mutation causes a milder form of Leigh syndrome compared to the T8993G mutation. This finding offers new insights into Leigh syndrome genetics and patient outcomes.
Area of Science:
- Genetics
- Mitochondrial Biology
- Neurology
Background:
- Maternally inherited Leigh syndrome (MILS) is often caused by the T8993G mitochondrial DNA mutation, typically leading to severe early-infancy mortality.
- A less aggressive juvenile form of Leigh syndrome (LS) was previously linked to the T8993C mutation.
Observation:
- This study describes four unrelated patients with the T8993C mutation presenting with diverse, mild clinical symptoms.
- The T8993C mutation was highly abundant (>94%) in various tissues of affected patients.
- Maternal relatives showed lower levels of the T8993C mutation in their blood.
Findings:
- Mitochondrial ATP production was normal in three patients but reduced in one patient (20-35% of controls).
- The T8993C mutation appears to be less severe than the T8993G mutation in Leigh syndrome.
- Heteroplasmy levels of the T8993C mutation varied between patients and tissues.
Implications:
- The T8993C mutation represents a distinct genetic cause of Leigh syndrome with a more favorable prognosis.
- Understanding mutation-specific severity can improve diagnosis and patient management for Leigh syndrome.
- Further research into mitochondrial DNA mutation impacts on cellular energy production is warranted.